Resumo

ALONSO, María Alonso et al. Intraoperative adenosine for pheochromocytoma with myocardial infarction and SARS-CoV-2. Case report. Rev. colomb. anestesiol. [online]. 2022, vol.50, n.3, e501.  Epub 28-Jul-2022. ISSN 0120-3347.  https://doi.org/10.5554/22562087.e1015.

Pheochromocytomas are neuroendocrine tumors capable of synthetizing, storing and releasing catecholaminergic hormones that may lead to lifethreatening hemodynamic instability. The COVID-19 pandemic has increased the risks and perioperative complexity of the patients undergoing pheochromocytoma-associated adrenalectomy. This article discusses the use of adenosine for the management of hypertensive crisis during this intervention, as well as the need to individualize the suitable timing for surgery after recent COVID-19 infection.

This article discusses the case of a patient with a finding of right adrenal incidentaloma; further studies determined a metanephrines secreting pheochromocytoma. Following hospital admission for preoperative optimization, the eve of the procedure the patient developed an acute myocardial infarction and subsequently SARS-CoV-2 symptomatic infection. Intraoperatively, hypertensive peaks were managed with continuous adenosine perfusion. The patient was discharged after 48 hours.

Preoperative optimization positively influences the intraoperative management of patients with pheochromocytoma. The intraoperative use of adenosine allows for adequate and safe control of hypertensive crises. Each situation must be individualized in patients pending surgery, with a recent COVID-19 infection.

Palavras-chave : Pheochromocytoma; COVID-19; Catecholamine; Hemodynamic monitoring; Adenosine triphosphate; Adrenergic antagonists; Anesthesiology.

        · resumo em Espanhol     · texto em Inglês | Espanhol     · Inglês ( pdf ) | Espanhol ( pdf )